This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

Friday, July 6, 2012

Diseases from animals hit 2 billion people a year

AppId is over the quota AppId is over the quota LONDON — A global study mapping human diseases that come from animals like tuberculosis, AIDS, bird flu or Rift Valley fever has found that just 13 such diseases are responsible for 2.4 billion cases of human illness and 2.2 million deaths a year.http://bit.ly/PpXe4G

Don't miss these Health stories After fighting for her life, mom finally gets to hold new baby After suffering a burst blood vessel in her brain while 38 weeks pregnant, Amber Scott was rushed to the hospital for an emergency C-section followed by brain surgery. After weeks of drifting in and out of consciousness, the new mom finally held her baby for the first time.
Love really can grow from lust, study says Something not so tasty in your barbecue -- brush debris The strange reason diet soda makes you fat Science cracks the code of what makes us cool The vast majority of infections and deaths from so-called zoonotic diseases are in poor or middle-income countries, but "hotspots" are also cropping up in the United States and Europe where diseases are newly infecting humans, becoming particularly virulent, or are developing drug resistance.
And exploding global demand for livestock products means the problem is likely to get worse, researchers said.
"From cyst-causing tapeworms to avian flu, zoonoses present a major threat to human and animal health," said Delia Grace, a veterinary epidemiologist and food safety expert with the International Livestock Research Institute (ILRI) in Kenya and lead author of the study.
She said targeting these diseases in the hardest hit countries is crucial to protecting global health, and failing to tackle them would allow demand for meat products to "fuel the spread of a wide range of human-animal infectious diseases."
The study, conducted by the ILRI, the Institute of Zoology in Britain and the Hanoi School of Public Health in Vietnam, mapped livestock-keeping and diseases humans get from animals, and drew up a list of the top 20 geographical hotspots.
It found that Ethiopia, Nigeria, and Tanzania, as well as India have the highest zoonotic disease burdens, with widespread illness and death.
It also found the United States and Europe - especially Britain - Brazil and parts of Southeast Asia may be becoming hotspots of "emerging zoonoses", which are infecting humans for the first time, are especially virulent or are becoming drug resistant.
The report studied so-called endemic zoonoses which cause the vast majority of illness and death in poor countries.
One such disease is brucellosis, also known as Bang's diseases or Mediterranean fever, which is a highly contagious zoonosis people catch by consuming unsterilized milk or meat from infected animals.
The researchers estimated that about one in eight livestock in poor countries are affected by brucellosis. As well as threatening people with disease, this also reduces milk and meat production in cattle by around 8 percent.
The study also looked at epidemic zoonoses, which typically occur as outbreaks - such as anthrax and Rift Valley fever - and at the relatively rarer emerging zoonoses like bird flu. A few of these, like HIV/AIDS and H1N1 swine flu, have shown the ability to spread to cause pandemics.
While zoonoses can be transmitted to people by either wild or domesticated animals, most human infections are acquired from the world's 24 billion livestock, including pigs, poultry, cattle, goats, sheep and camels.
The study initially looked at 56 zoonoses that together are responsible for around 2.5 billion cases of human illness and 2.7 million human deaths per year.
It then zoomed in on the 13 most important, and found high levels of infection with these in livestock in poor countries.
Some 27 percent of livestock in developing countries showed signs of current or past infection with bacterial food-borne disease - a source of food contamination and widespread illness.
The researchers estimated at least a third of the world's cases of diarrhoeal disease are caused by animal-human diseases and said this was the biggest zoonotic threat to public health.
John McDermott, director of the CGIAR research program on agriculture for nutrition and health led by the International Food Policy Research Institute (IFPRI), said that in booming livestock sectors in developing nations the fastest growing areas are poultry and pigs - putting the potential disease risk emphasis on flu.
"Historically, high-density pig and poultry populations have been important in maintaining and mixing influenza populations," he said in a statement accompanying the study.
"A major concern is that as new livestock systems intensify, particularly small- and medium-sized pig production ... more intensive systems will allow the maintenance and transmission of pathogens. A number of new zoonoses ... have emerged in that way."

Is summertime bringing new wave of ads for artificial knees?

I was watching the NBC Nightly News the other night and saw a Stryker ad for its GetAroundKnee.com.  I couldn’t find the TV commercial online, but this is from their website:

That same day, I found this ad in the July issue of Prevention magazine.

Together, hip and knee replacement surgeries already represent the largest hospital expense for Medicare. And, according to an article in Time magazine, the money spent on these two procedures is expected to reach $65.2 billion by 2015.

There is no doubt that part of Medicare reform will involve looking at ways to reduce this cost. One approach is to move the choice of device away from vague “physician preference” and toward evidence-based criteria. The goal will be to use comparative-effectiveness studies to identify which implants are the best-performing, longest-lasting and most cost-effective devices. Many countries have established national registries for hip and knee implant surgeries that include a record of each surgery, the type of device used and reports of complications. Such a registry would improve patient safety and quality of care, according to a report by Kaiser Permanente researchers that was published in November in the Journal of Bone and Joint Surgery. It would make it easier to counsel patients, identify risk factors, track implanted devices during recalls and assess comparative effectiveness of devices, according to lead author Elizabeth Paxton, director of surgical outcomes and analysis at Kaiser.

The American Joint Replacement Registry was created recently, and just this January began a pilot project collecting hip and knee replacement information from 16 representative hospitals. In a statement, the organization (made up of surgeons, executives from the device industry, payers and patient representatives) said that its “long-term goal is to capture data from 90 percent of U.S. hospitals where hip and knee arthroplasty procedures are performed, which amounts to between 5,000 and 6,000 different hospitals, in the next 5 years.”

In the end, marketing devices directly to consumers is antithetical to these other measures that are designed to promote evidence-based treatments. One argument that drug companies have always made to support their (direct-to-consumer) DTC ads is that they are “educational” for consumers. And there may in fact be men in their 40’s or 50’s with degenerative hip disease or other painful, disabling condition that learn about hip resurfacing from a TV ad. Maybe they find out that they don’t have to spend 15 more years disabled as they wait for a total hip replacement. These newly educated fellows may then go to an orthopedic surgeon who (with no conflict of interest) helps them decide whether this is the right approach for them. That is educational.

But DTC ads cast a very wide net. And they work to draw in a wide customer base, raising expectations and brushing over risks and cheaper options. If they didn’t do this, companies like Smith & Nephew wouldn’t spend millions running them. Unless insurers—both public and private—start using evidence-based decision making to set coverage for new hip implant devices, the number of younger patients undergoing more expensive procedures will likely rise—sometimes for the wrong reasons.

We’ll continue to watch.


View the original article here

Is summertime bringing new wave of ads for artificial knees?

I was watching the NBC Nightly News the other night and saw a Stryker ad for its GetAroundKnee.com.  I couldn’t find the TV commercial online, but this is from their website:

That same day, I found this ad in the July issue of Prevention magazine.

Together, hip and knee replacement surgeries already represent the largest hospital expense for Medicare. And, according to an article in Time magazine, the money spent on these two procedures is expected to reach $65.2 billion by 2015.

There is no doubt that part of Medicare reform will involve looking at ways to reduce this cost. One approach is to move the choice of device away from vague “physician preference” and toward evidence-based criteria. The goal will be to use comparative-effectiveness studies to identify which implants are the best-performing, longest-lasting and most cost-effective devices. Many countries have established national registries for hip and knee implant surgeries that include a record of each surgery, the type of device used and reports of complications. Such a registry would improve patient safety and quality of care, according to a report by Kaiser Permanente researchers that was published in November in the Journal of Bone and Joint Surgery. It would make it easier to counsel patients, identify risk factors, track implanted devices during recalls and assess comparative effectiveness of devices, according to lead author Elizabeth Paxton, director of surgical outcomes and analysis at Kaiser.

The American Joint Replacement Registry was created recently, and just this January began a pilot project collecting hip and knee replacement information from 16 representative hospitals. In a statement, the organization (made up of surgeons, executives from the device industry, payers and patient representatives) said that its “long-term goal is to capture data from 90 percent of U.S. hospitals where hip and knee arthroplasty procedures are performed, which amounts to between 5,000 and 6,000 different hospitals, in the next 5 years.”

In the end, marketing devices directly to consumers is antithetical to these other measures that are designed to promote evidence-based treatments. One argument that drug companies have always made to support their (direct-to-consumer) DTC ads is that they are “educational” for consumers. And there may in fact be men in their 40’s or 50’s with degenerative hip disease or other painful, disabling condition that learn about hip resurfacing from a TV ad. Maybe they find out that they don’t have to spend 15 more years disabled as they wait for a total hip replacement. These newly educated fellows may then go to an orthopedic surgeon who (with no conflict of interest) helps them decide whether this is the right approach for them. That is educational.

But DTC ads cast a very wide net. And they work to draw in a wide customer base, raising expectations and brushing over risks and cheaper options. If they didn’t do this, companies like Smith & Nephew wouldn’t spend millions running them. Unless insurers—both public and private—start using evidence-based decision making to set coverage for new hip implant devices, the number of younger patients undergoing more expensive procedures will likely rise—sometimes for the wrong reasons.

We’ll continue to watch.


View the original article here

Top articles in medicine in may 2012

AppId is over the quota
AppId is over the quota
Here are my suggestions for some of the top articles in medicine in May 2012 so far:

Point-of-care genetic testing for personalisation of antiplatelet treatment is effective http://goo.gl/ZWLvz

Patient empowerment - who empowers whom? Virtually all people are patients at some point in their lives http://goo.gl/4YKjq

Doctors' love-hate relationship with EHRs http://goo.gl/wd74F

Why U.S. spends more on healthcare than other developed countries: Higher prices, readily accessible technology, obesity http://goo.gl/cid6S

Austerely law transforms Spain’s health system from universal access to one based on employment | BMJ http://goo.gl/36u4C

Bevacizumab (Avastin) is as effective as ranibizumab (Lucentis) for wet AMD and could save NHS millions - NHS http://goo.gl/JJ8uV

Having 'Type D' Personality - a distressed and pessimistic outlook on life - May Affect Your Health http://goo.gl/kFbpA

New Cautions About Bisphosphonate Use - NYTimes http://goo.gl/PYiKy

How to Create Your Own Website using Blogger - Step-by-Step Guide for Physicians http://goo.gl/tCd37

Truvada (Emtriva + Viread), first drug to prevent HIV infection in healthy people at high risk (MSM, partners of HIV+) http://goo.gl/e1MJM

Can mobile phones give you brain cancer? The verdict's still on hold http://goo.gl/gI6Ta

Drink Water to Improve Test Scores http://goo.gl/MNB6k and http://goo.gl/EO12p

The articles were selected from my Twitter and Google Reader streams.


View the original article here

Top articles in medicine in may 2012

AppId is over the quota
AppId is over the quota
Here are my suggestions for some of the top articles in medicine in May 2012 so far:

Point-of-care genetic testing for personalisation of antiplatelet treatment is effective http://goo.gl/ZWLvz

Patient empowerment - who empowers whom? Virtually all people are patients at some point in their lives http://goo.gl/4YKjq

Doctors' love-hate relationship with EHRs http://goo.gl/wd74F

Why U.S. spends more on healthcare than other developed countries: Higher prices, readily accessible technology, obesity http://goo.gl/cid6S

Austerely law transforms Spain’s health system from universal access to one based on employment | BMJ http://goo.gl/36u4C

Bevacizumab (Avastin) is as effective as ranibizumab (Lucentis) for wet AMD and could save NHS millions - NHS http://goo.gl/JJ8uV

Having 'Type D' Personality - a distressed and pessimistic outlook on life - May Affect Your Health http://goo.gl/kFbpA

New Cautions About Bisphosphonate Use - NYTimes http://goo.gl/PYiKy

How to Create Your Own Website using Blogger - Step-by-Step Guide for Physicians http://goo.gl/tCd37

Truvada (Emtriva + Viread), first drug to prevent HIV infection in healthy people at high risk (MSM, partners of HIV+) http://goo.gl/e1MJM

Can mobile phones give you brain cancer? The verdict's still on hold http://goo.gl/gI6Ta

Drink Water to Improve Test Scores http://goo.gl/MNB6k and http://goo.gl/EO12p

The articles were selected from my Twitter and Google Reader streams.


View the original article here

Thursday, July 5, 2012

Top articles in medicine in May 2012

AppId is over the quota
AppId is over the quota
Here are my suggestions for some of the top articles in medicine in May 2012 so far:

Point-of-care genetic testing for personalisation of antiplatelet treatment is effective http://goo.gl/ZWLvz

Patient empowerment - who empowers whom? Virtually all people are patients at some point in their lives http://goo.gl/4YKjq

Doctors' love-hate relationship with EHRs http://goo.gl/wd74F

Why U.S. spends more on healthcare than other developed countries: Higher prices, readily accessible technology, obesity http://goo.gl/cid6S

Austerely law transforms Spain’s health system from universal access to one based on employment | BMJ http://goo.gl/36u4C

Bevacizumab (Avastin) is as effective as ranibizumab (Lucentis) for wet AMD and could save NHS millions - NHS http://goo.gl/JJ8uV

Having 'Type D' Personality - a distressed and pessimistic outlook on life - May Affect Your Health http://goo.gl/kFbpA

New Cautions About Bisphosphonate Use - NYTimes http://goo.gl/PYiKy

How to Create Your Own Website using Blogger - Step-by-Step Guide for Physicians http://goo.gl/tCd37

Truvada (Emtriva + Viread), first drug to prevent HIV infection in healthy people at high risk (MSM, partners of HIV+) http://goo.gl/e1MJM

Can mobile phones give you brain cancer? The verdict's still on hold http://goo.gl/gI6Ta

Drink Water to Improve Test Scores http://goo.gl/MNB6k and http://goo.gl/EO12p

The articles were selected from my Twitter and Google Reader streams.


View the original article here

Top articles in medicine in May 2012

AppId is over the quota
AppId is over the quota
Here are my suggestions for some of the top articles in medicine in May 2012 so far:

Point-of-care genetic testing for personalisation of antiplatelet treatment is effective http://goo.gl/ZWLvz

Patient empowerment - who empowers whom? Virtually all people are patients at some point in their lives http://goo.gl/4YKjq

Doctors' love-hate relationship with EHRs http://goo.gl/wd74F

Why U.S. spends more on healthcare than other developed countries: Higher prices, readily accessible technology, obesity http://goo.gl/cid6S

Austerely law transforms Spain’s health system from universal access to one based on employment | BMJ http://goo.gl/36u4C

Bevacizumab (Avastin) is as effective as ranibizumab (Lucentis) for wet AMD and could save NHS millions - NHS http://goo.gl/JJ8uV

Having 'Type D' Personality - a distressed and pessimistic outlook on life - May Affect Your Health http://goo.gl/kFbpA

New Cautions About Bisphosphonate Use - NYTimes http://goo.gl/PYiKy

How to Create Your Own Website using Blogger - Step-by-Step Guide for Physicians http://goo.gl/tCd37

Truvada (Emtriva + Viread), first drug to prevent HIV infection in healthy people at high risk (MSM, partners of HIV+) http://goo.gl/e1MJM

Can mobile phones give you brain cancer? The verdict's still on hold http://goo.gl/gI6Ta

Drink Water to Improve Test Scores http://goo.gl/MNB6k and http://goo.gl/EO12p

The articles were selected from my Twitter and Google Reader streams.


View the original article here

Everyday Health Editors' Product Review Blog

Reuters: Business Travel

MedicineNet Nutrition, Food and Recipes General

Pages

MedicineNet Diet and Weight Management General

Frommer's Deals and News

Behind the Guides

Media Releases: News Desk

About.com Day Trading

Frommers.com Cruise Blog

Arthur Frommer Online

Dictionary.com Word of the Day

The Full Feed from HuffingtonPost.com